Baker Bros. Capital (GP), LLC Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC
Get free email notifications about insider trading for Baker Bros. Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Bros. Capital (GP), LLC. Baker Bros. Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Bros. Capital (GP), LLC in BIOCRYST PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 71,997 shares
Current Value: $408,223
Latest Transaction: Jun 01 2009
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Bros. Capital (GP), LLC in BIOCRYST PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 3.89 | 3,124 | 12,137 | 71,997 | 75.1 K to 72 K (-4.16 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 3.86 | 8,067 | 31,172 | 75,121 | 83.2 K to 75.1 K (-9.70 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 4.12 | 7,726 | 31,853 | 83,188 | 90.9 K to 83.2 K (-8.50 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 4.30 | 1,500 | 6,452 | 90,914 | 92.4 K to 90.9 K (-1.62 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 4.50 | 11,128 | 50,122 | 92,414 | 103.5 K to 92.4 K (-10.75 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 4.45 | 6,174 | 27,496 | 103,542 | 109.7 K to 103.5 K (-5.63 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 0.98 | 10 | 10 | 109,716 | 109.7 K to 109.7 K (+0.01 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 0.91 | 43 | 39 | 109,706 | 109.7 K to 109.7 K (+0.04 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 1.00 | 422 | 422 | 109,663 | 109.2 K to 109.7 K (+0.39 %) |
Page: 1